Malirid 7.5mg Tablet contains primaquine 7.5 mg and belongs to the antimalarial class of medicines. It is used under medical supervision for malaria, particularly as part of treatment intended to eliminate certain malaria parasites that can remain dormant in the liver and cause relapse. Product information identifies primaquine as the active ingredient in this strength.

What Is Malirid 7.5mg Tablet?

Malirid 7.5mg Tablet is an oral prescription antimalarial containing primaquine. Unlike medicines that primarily target parasites circulating in the bloodstream, primaquine has activity against liver-stage parasites associated with relapsing malaria, especially Plasmodium vivax. U.S. prescribing information describes primaquine phosphate as indicated for the radical cure, or prevention of relapse, of vivax malaria.

Because malaria treatment depends on the infecting species, geographic origin of the infection, previous medicines, age, weight, and laboratory findings, patients should not select this medicine based only on symptoms. A healthcare professional should confirm the diagnosis and determine the appropriate antimalarial regimen. The CDC recommends primaquine as an anti-relapse option for confirmed P. vivax and P. ovale infections after quantitative G6PD testing.

How Malirid 7.5mg Tablet Works

Malirid 7.5mg Tablet works through primaquine, an 8-aminoquinoline antimalarial. It helps eliminate malaria parasites that can persist in liver tissue after the blood-stage infection has been addressed. Removing these dormant forms is important because they can reactivate later and produce another episode of malaria.

This medicine does not mean that every malaria infection can be treated with primaquine alone. Acute malaria may require a different antimalarial to clear parasites from the bloodstream. Your clinician chooses treatment according to the malaria species and resistance pattern. The CDC specifically notes that additional anti-relapse treatment is needed for P. vivax and P. ovale because liver hypnozoites can cause recurrence.

Uses and Potential Benefits

Malirid 7.5mg Tablet may be prescribed when a clinician needs primaquine therapy for malaria management or prevention of relapse. Its principal role is to help eliminate susceptible liver-stage parasites after appropriate treatment of the acute infection. This can reduce the likelihood of malaria returning because of dormant parasites.

Patients should understand that malaria is a serious parasitic disease and should never rely on self-treatment based on an online product description. Fever, chills, sweating, headache, weakness, nausea, or other symptoms can occur with malaria but can also occur with other illnesses. Prompt diagnosis is essential, particularly after travel or residence in a malaria-endemic region.

Related Product

How to Take Malirid 7.5mg Tablet

Take Malirid 7.5mg Tablet exactly according to the prescription provided by your healthcare professional. Product information recommends taking the tablet with or after food to reduce stomach discomfort and swallowing it whole with water. Do not crush, chew, or break the tablet unless your prescriber or pharmacist specifically instructs you to do so.

Do not change the dose or treatment duration yourself. Primaquine dosing is based on factors such as malaria species, body weight, treatment objective, and G6PD status. Current CDC guidance for U.S. adults uses primaquine 30 mg base daily for 14 days for anti-relapse treatment, with weight-based adjustments for people weighing at least 70 kg. Therefore, the 7.5 mg tablet strength should not be interpreted as a standard adult daily dose.

If you miss a dose of Malirid 7.5 mg Tablet, follow your prescriber’s instructions. Do not take two doses together unless a healthcare professional specifically tells you to do so. Completing the prescribed regimen helps ensure appropriate treatment.

Important G6PD Safety Warning

Before taking Malirid 7.5 mg Tablet, patients need appropriate G6PD evaluation when primaquine is being considered. Primaquine can cause hemolytic anemia in people with G6PD deficiency, and the risk can be serious. Current CDC guidance requires quantitative G6PD testing before anti-relapse primaquine therapy.

Contact a healthcare professional immediately if you develop dark urine, unusual tiredness, pale skin, shortness of breath, dizziness, or other symptoms that could indicate hemolysis. U.S. prescribing information specifically warns about hemolytic reactions and recommends prompt discontinuation and medical assessment when concerning symptoms occur.

Pregnancy and Breastfeeding

Malirid 7.5 mg Tablet should not be used during pregnancy because primaquine can cause hemolytic anemia in a G6PD-deficient fetus, even when the mother has normal G6PD activity. Breastfeeding also requires individualized medical assessment because the infant’s G6PD status matters.

Tell your healthcare professional if you are pregnant, planning pregnancy, or breastfeeding before receiving primaquine therapy. Do not begin treatment based solely on information from an online pharmacy listing.

Possible Side Effects

Malirid 7.5 mg Tablet may cause gastrointestinal discomfort, nausea, vomiting, abdominal pain, headache, dizziness, rash, itching, or other reactions. Product information also reports potentially serious blood-related effects and abnormal heart rhythms.

Seek urgent medical attention for severe weakness, breathing difficulty, dark urine, marked paleness, fainting, severe allergic symptoms, or an irregular heartbeat. Tell your healthcare professional about persistent or worsening symptoms rather than continuing treatment without advice.

Drug Interactions and Precautions

Tell your doctor and pharmacist about every prescription medicine, over-the-counter product, vitamin, and supplement you use. Primaquine may interact with medicines that increase the risk of blood-related toxicity or otherwise alter its effects. Quinacrine, for example, is specifically contraindicated with primaquine because it can increase toxicity.

Store Malirid 7.5 mg Tablet according to the product label and keep it away from children. Because malaria treatment can involve multiple medicines, keep an accurate list of everything you take and show it to your prescriber or pharmacist.

Ordering and Prescription Information

Malirid 7.5mg Tablet is a prescription medicine in the product listings reviewed for this description. If you are considering an online purchase, use only a properly licensed pharmacy that verifies the prescription when required and provides authentic, correctly labeled medication.

For U.S. patients, note that the specific Malirid brand and 7.5 mg strength may not correspond to the U.S. marketed primaquine products. U.S. labeling describes primaquine phosphate tablets in a different strength, so a clinician or pharmacist should verify the product and strength before dispensing or substituting it.

Frequently Asked Questions

Is Malirid 7.5mg Tablet used for malaria?

Yes. Malirid 7.5mg Tablet contains primaquine and is used in malaria management, particularly for eliminating liver-stage parasites associated with relapse.

Does Malirid 7.5mg Tablet cure malaria by itself?

Not necessarily. Malirid 7.5mg Tablet may address liver-stage parasites, while another antimalarial may be required to treat the acute blood-stage infection. Your clinician determines the complete regimen.

Do I need a G6PD test before taking it?

Yes. Malirid 7.5mg Tablet contains primaquine, which can cause serious hemolysis in people with G6PD deficiency. Quantitative G6PD testing should be completed before appropriate primaquine therapy.

Can I take Malirid 7.5mg Tablet during pregnancy?

No. Malirid 7.5mg Tablet should not be used during pregnancy because primaquine is contraindicated due to potential fetal hemolytic risk.

Should I take Malirid 7.5mg Tablet with food?

Product information recommends taking Malirid 7.5mg Tablet with or after food to reduce gastrointestinal discomfort.